No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract: Pertuzumab plus trastuzumab significantly improves survival in metastatic breast cancer

byTeddy Guo

March 23, 2022

in StudyGraphics

Reading Time: 1 min read

Vaccine booster after Johnson & Johnson-Janssen priming are safe and immunogenic

RelatedReports

Variability in interpretation of breast biopsy slides associated with low verification of atypia and ductal carcinoma in situ

Chronic Disease

Statin use after but not before breast cancer diagnosis is associated with improved mortality in hormone receptor-positive early breast cancer

June 8, 2026

Weekly Rewinds

2 Minute Medicine Rewind June 8, 2026

June 8, 2026

3D mammography (tomosynthesis) enhances accuracy of breast cancer screening

Oncology

Sentinel lymph node biopsy may reduce the need for axillary dissection in cN1 breast cancer

May 20, 2026

Development of a risk index for colorectal cancer screening

Chronic Disease

Sequential compared to upfront treatment of metastatic colorectal cancer using oxaliplatin (Eloxatin) therapy may lead to similar outcomes

May 12, 2026

Large proportion of late preterm infants and older admitted to the NICU

Neonatal hypoglycemia not significantly associated with lower educational achievement during childhood

Multiple variables related to physical activity levels in preschool children

Cardiosphere-derived cell therapy slows disease progression in Duchenne muscular dystrophy

Wellness Check: Spirituality

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports